tapioca starch
Botanicalexperimental
Tapioca is a starch extracted from the tubers of the cassava plant, a species native to the North and Northeast regions of Brazil, but which has now spread throughout parts of the world such as West Africa and Southeast Asia. It is a perennial shrub adapted to the hot conditions of tropical lowlands. Cassava copes better with poor soils than many other food plants. — Wikipedia
Clinical trial activity
2 trials · 2 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
1
Phase 3
0
Phase 4
0
Earliest trial started Sep 1, 2017 (NCT03255603)
Timeline
2020s
- Jan 1, 2022
Earliest Phase 1 Sponsor(trial)
Indications
Mechanism of action
- Unspecified targetUnclear
Unclear
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaTapioca ↗
- NCATS24SC3U704I ↗
Also known as
- tapioca starch
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT04700527 | Phase 1/Phase 2 (Phase 2) | Apr 30, 2022 | University of North Carolina at Chapel Hill |
| NCT03255603 | N/A | Sep 1, 2017 | University of Alberta |
Showing 2 of 2 trials
Page 1 / 1
Organizations
Research & Development (2)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| University of Alberta | Academic/Hospital | 1 | 1 | 1 | 2017 |
| University of North Carolina at Chapel Hill | Academic/Hospital | 1 | 1 | 1 | 2022 |
2 organizations
Page 1 / 1